Back to Companies
JOHNSON & JOHNSON
JNJNYSECIK: 0000200406
Recent Form 4 activity at JOHNSON & JOHNSON (JNJ) spans 50 filings across 22 insiders (all of them on the sell side). Purchases total $0 against $140.4M in sales — heavily weighted toward selling, for net sales of $140.4M. Duato Joaquin (CEO and Chairman of the Board, Director) is the most active by dollar volume, and the single largest transaction was $60.7M by Duato Joaquin. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$398.9M
Purchases
$0
Sales
$140.4M
Unique Insiders
22
Recent Insider Trades
50 loaded
| Aug 18 | JNJ JOHNSON & JOHNSON | Taubert Jennifer L | EVP, WWC. Innovative Medicine | Sell | $4.0M |
| Aug 14 | JNJ JOHNSON & JOHNSON | Duato Joaquin | CEO and Chairman of the Board, Director | Sell | $32.2M |
| Aug 7 | JNJ JOHNSON & JOHNSON | Forminard Elizabeth | EVP, Chief Legal Officer | Sell | $4.1M |
| Aug 7 | JNJ JOHNSON & JOHNSON | Duato Joaquin | CEO and Chairman of the Board, Director | Sell | $12.5M |
| Jul 21 | JNJ JOHNSON & JOHNSON | Broadhurst Vanessa | EVP, Global Corp Affairs | Sell | $5.8M |
| Jun 12 | JNJ JOHNSON & JOHNSON | Wengel Kathryn E | EVP, Chief TO and Risk Officer | Sell | $2.4M |
| Jun 11 | JNJ JOHNSON & JOHNSON | HEWSON MARILLYN A | Director | Award | $0 |
| Jun 11 | JNJ JOHNSON & JOHNSON | Woods Eugene A. | Director | Award | $0 |
| Jun 11 | JNJ JOHNSON & JOHNSON | Pinto Daniel E | Director | Award | $0 |
| May 4 | JNJ JOHNSON & JOHNSON | REED JOHN C | EVP, Innovative Medicine, R&D | Exercise | $2.5M |
| Apr 27 | JNJ JOHNSON & JOHNSON | MORIKIS JOHN G | Director | Award | $0 |
| Apr 27 | JNJ JOHNSON & JOHNSON | WEINBERGER MARK A | Director | Award | $0 |
| Apr 27 | JNJ JOHNSON & JOHNSON | HEWSON MARILLYN A | Director | Award | $0 |
| Apr 27 | JNJ JOHNSON & JOHNSON | West Nadja | Director | Award | $0 |
| Apr 27 | JNJ JOHNSON & JOHNSON | Joly Hubert | Director | Award | $0 |
| Apr 27 | JNJ JOHNSON & JOHNSON | Woods Eugene A. | Director | Award | $0 |
| Apr 27 | JNJ JOHNSON & JOHNSON | Beckerle Mary C | Director | Award | $0 |
| Apr 27 | JNJ JOHNSON & JOHNSON | Pinto Daniel E | Director | Award | $0 |
| Apr 27 | JNJ JOHNSON & JOHNSON | Johnson Paula A | Director | Award | $0 |
| Apr 27 | JNJ JOHNSON & JOHNSON | Doudna Jennifer A | Director | Award | $0 |
| Apr 27 | JNJ JOHNSON & JOHNSON | McClellan Mark B. | Director | Award | $0 |
| Mar 12 | JNJ JOHNSON & JOHNSON | Woods Eugene A. | Director | Award | $0 |
| Mar 12 | JNJ JOHNSON & JOHNSON | Pinto Daniel E | Director | Award | $0 |
| Feb 23 | JNJ JOHNSON & JOHNSON | Schmid Timothy | EVP, WW Chair, MedTech | Sell | $324.8K |
| Feb 18 | JNJ JOHNSON & JOHNSON | REED JOHN C | EVP, Innovative Medicine, R&D | Sell | $13.1M |
| Feb 18 | JNJ JOHNSON & JOHNSON | Duato Joaquin | CEO and Chairman of the Board, Director | Exercise | $40.9M |
| Feb 18 | JNJ JOHNSON & JOHNSON | Broadhurst Vanessa | EVP, Global Corp Affairs | Sell | $1.5M |
| Feb 18 | JNJ JOHNSON & JOHNSON | Taubert Jennifer L | EVP, WWC. Innovative Medicine | Exercise | $17.2M |
| Feb 18 | JNJ JOHNSON & JOHNSON | Swanson James D. | EVP, CIO | Sell | $15.1M |
| Feb 18 | JNJ JOHNSON & JOHNSON | Mulholland Kristen | EVP, Chief HR Officer | Exercise | $5.3M |
| Feb 18 | JNJ JOHNSON & JOHNSON | Schmid Timothy | EVP, WW Chair, MedTech | Sell | $5.5M |
| Feb 18 | JNJ JOHNSON & JOHNSON | Wolk Joseph J | Exec VP, CFO | Sell | $21.8M |
| Feb 18 | JNJ JOHNSON & JOHNSON | Wengel Kathryn E | EVP, Chief TO and Risk Officer | Exercise | $5.9M |
| Feb 18 | JNJ JOHNSON & JOHNSON | Decker Robert J | VP Corporate Controller | Exercise | $1.4M |
| Feb 18 | JNJ JOHNSON & JOHNSON | Forminard Elizabeth | EVP, Chief Legal Officer | Exercise | $8.6M |
| Feb 11 | JNJ JOHNSON & JOHNSON | Duato Joaquin | CEO and Chairman of the Board, Director | Award | $0 |
| Feb 11 | JNJ JOHNSON & JOHNSON | Swanson James D. | EVP, CIO | Award | $0 |
| Feb 11 | JNJ JOHNSON & JOHNSON | Mulholland Kristen | EVP, Chief HR Officer | Award | $0 |
| Feb 11 | JNJ JOHNSON & JOHNSON | Decker Robert J | VP Corporate Controller | Award | $0 |
| Feb 11 | JNJ JOHNSON & JOHNSON | Forminard Elizabeth | EVP, Chief Legal Officer | Award | $0 |
| Feb 11 | JNJ JOHNSON & JOHNSON | Schmid Timothy | EVP, WW Chair, MedTech | Award | $0 |
| Feb 11 | JNJ JOHNSON & JOHNSON | Wolk Joseph J | Exec VP, CFO | Award | $0 |
| Feb 11 | JNJ JOHNSON & JOHNSON | Wengel Kathryn E | EVP, Chief TO and Risk Officer | Award | $0 |
| Feb 11 | JNJ JOHNSON & JOHNSON | Broadhurst Vanessa | EVP, Global Corp Affairs | Award | $0 |
| Feb 11 | JNJ JOHNSON & JOHNSON | Taubert Jennifer L | EVP, WWC. Innovative Medicine | Award | $0 |
| Feb 9 | JNJ JOHNSON & JOHNSON | Mulholland Kristen | EVP, Chief HR Officer | Exercise | $1.9M |
| Feb 9 | JNJ JOHNSON & JOHNSON | Wengel Kathryn E | EVP, Chief TO and Risk Officer | Exercise | $14.5M |
| Feb 10 | JNJ JOHNSON & JOHNSON | Schmid Timothy | EVP, WW Chair, MedTech | Exercise | $5.7M |
| Feb 6 | JNJ JOHNSON & JOHNSON | Forminard Elizabeth | EVP, Chief Legal Officer | Exercise | $3.8M |
| Jan 28 | JNJ JOHNSON & JOHNSON | Duato Joaquin | CEO and Chairman of the Board, Director | Sell | $22.1M |
50 filings+